SEPTIN9 and cancer: For instance, Jung et al. evaluated SHOX2 and SEPTIN9 methylation in ascites and reported that the combination of both markers increased the detection rate of malignant ascites by 42% when combined with cytology, achieving a sensitivity of 37% at 97% specificity in a cohort of 134 cancer patients (Jung et al., 2016).